key: cord-1040742-ol6kmvlf authors: Franceschi, Vinícius Bonetti; Santos, Andressa Schneiders; Glaeser, Andressa Barreto; Paiz, Janini Cristina; Caldana, Gabriel Dickin; Machado Lessa, Carem Luana; de Menezes Mayer, Amanda; Küchle, Julia Gonçalves; Gazzola Zen, Paulo Ricardo; Vigo, Alvaro; Winck, Ana Trindade; Rotta, Liane Nanci; Thompson, Claudia Elizabeth title: Population‐based prevalence surveys during the Covid‐19 pandemic: A systematic review date: 2020-12-04 journal: Rev Med Virol DOI: 10.1002/rmv.2200 sha: 84cf6255f4151713c22ce633e04a96cae460df14 doc_id: 1040742 cord_uid: ol6kmvlf Population‐based prevalence surveys of Covid‐19 contribute to establish the burden of infection, the role of asymptomatic and mild infections in transmission, and allow more precise decisions about reopen policies. We performed a systematic review to evaluate qualitative aspects of these studies, assessing their reliability and compiling practices that can influence the methodological quality. We searched MEDLINE, EMBASE, bioRxiv and medRxiv, and included cross‐sectional studies using molecular and/or serological tests to estimate the prevalence of Covid‐19 in the general population. Survey quality was assessed using the Joanna Briggs Institute Critical Appraisal Checklist for Prevalence Studies. A correspondence analysis correlated methodological parameters of each study to identify patterns related to higher, intermediate and lower risks of bias. The available data described 37 surveys from 19 countries. The majority were from Europe and America, used antibody testing, and reached highly heterogeneous sample sizes and prevalence estimates. Minority communities were disproportionately affected by Covid‐19. Important risk of bias was detected in four domains: sample size, data analysis with sufficient coverage, measurements in standard way and response rate. The correspondence analysis showed few consistent patterns for high risk of bias. Intermediate risk of bias was related to American and European studies, municipal and regional initiatives, blood samples and prevalence >1%. Low risk of bias was related to Asian studies, nationwide initiatives, reverse‐transcriptase polymerase chain reaction tests and prevalence <1%. We identified methodological standards applied worldwide in Covid‐19 prevalence surveys, which may assist researchers with the planning, execution and reporting of future population‐based surveys. of bias was detected in four domains: sample size, data analysis with sufficient coverage, measurements in standard way and response rate. The correspondence analysis showed few consistent patterns for high risk of bias. Intermediate risk of bias was related to American and European studies, municipal and regional initiatives, blood samples and prevalence >1%. Low risk of bias was related to Asian studies, nationwide initiatives, reverse-transcriptase polymerase chain reaction tests and prevalence <1%. We identified methodological standards applied worldwide in Covid-19 prevalence surveys, which may assist researchers with the planning, execution and reporting of future population-based surveys. Covid-19, cross-sectional studies, epidemiology, infectious diseases, prevalence, SARS-CoV-2, severe acute respiratory syndrome coronavirus 2 In December 2019, the third most important coronavirus in the twenty-first century (severe acute respiratory syndrome coronavirus 2 -SARS-CoV-2) was identified as the causative agent of SARS outbreak in Wuhan, Hubei province, China. 1,2 SARS-CoV-2 has spread rapidly around the world leading the disease (Covid-19) to acquire pandemic status on 11 March 2020. 3 As of 14 October 2020, there are ∼38 million confirmed cases and ∼1.1 million reported deaths in 216 countries, areas or territories. More than 50% of these cases were reported in the United States, India and Brazil, the worsthit countries. 4, 5 According to the current evidence, the main form of SARS-CoV-2 spreading is through human-to-human transmission via respiratory droplets and contact routes. 6 The standard diagnostic testing method is the reverse-transcriptase polymerase chain reaction (RT-PCR) test, 7, 8 which is able to detect current infections, and it is recommended for people with Covid-19 symptoms and for all close contacts of the confirmed cases. A complementary approach is to use antibody tests (e.g., point-of-care test or enzyme-linked immunosorbent assay) to detect a past infection and the production of antibodies (IgM and/or IgG) against SARS-CoV-2. 8 Covid-19 causes diverse degrees of illness, ranging from asymptomatic infection to severe pneumonia. 9 However, surveillance is only based on the confirmed cases, which can represent an underestimation of total cases due to non-testing in mildly affected or asymptomatic individuals. Population-based prevalence surveys can help to establish the disease epidemiology, the burden of infection, the role that asymptomatic and mild infections play in the transmission, and to enable precise evidence-based decisions about control and reopen policies, while no pharmacological intervention is available. 10 Moreover, accurate estimates of the basic reproduction number, of exposed and susceptible populations, and the fatality rates can be obtained. 11, 12 Statistical extrapolations will only be reliable for the population if (i) the sample of individuals is sufficient, random and representative of the general population; (ii) if the measurements are standardized and (iii) if the tests used have adequate sensitivity and specificity, among other factors. 13 For example, a recent systematic review and meta-analysis evaluated the diagnostic accuracy of serological tests in 40 studies. The conclusion indicated that the use of existing pointof-care serological tests is not supported by available evidence due to low performance. 14 Thus, a critical evaluation of these parameters is necessary to verify the reliability of the population-based surveys of Covid-19. We performed a systematic review to evaluate and summarize the main results regarding the Covid-19 prevalence obtained through population-based surveys, their reliability and biases. Our main aims were to evaluate the qualitative aspects of these studies and to compile practices that can influence positively or negatively the methodological quality. The protocol for this systematic review was registered on PROS-PERO (ID: CRD42020202186). Reporting was conducted according to Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) (Supplementary Checklist). The review included cross-sectional or repeated cross-sectional studies using molecular or serological tests to estimate the preva- (Table 1) . Disagreements in the screening and data extraction were discussed among the reviewers and, if consensus cannot be reached, a third reviewer (ATW) made the ultimate decision. We assessed each survey quality by using the Joanna Briggs Institute (JBI) Critical Appraisal Checklist for Prevalence Studies. 13 Of 49 full-text articles screened, we excluded 12 (Table S2) , and identified 37 eligible for extensive review (Figure 1 , Table 1 In total, 19 countries had studies included in this analysis (Figure 2 hand, the use of the gold standard (RT-PCR) was associated with low risk of bias. P < 1% was more frequent in studies with low risk of bias, while P > 1% was associated with intermediate risk of bias. Some categories presented in Figure 5 have not been reported here after manual examination due to their low frequency (e.g., Africa, BioS: Uninformed, S: <80%). We observed that important limitations of the studies were the low sample size and the low response rate (Figure 4 ). These factors influence heavily on reliable prevalence estimates. 53 Moreover, the recruitment by letter, by mail or online may play a significant role in reducing the response rate and inadequately address the target population. 54, 55 For example, in the Icelandic study, 27 the authors discussed the small variation in the prevalence estimates between open invitation and random selection recruitments. However, the random selection methods were not detailed and the sample size to detect the estimated prevalence was not adequate (<2529 individuals). 56 In the Slovenian study, 31 despite being considered nationwide, the sample size was 1366, which represented ∼7� less than necessary (10,179), 56 and there was no management of the low response rate (<50%). Some authors seem to have not been concerned with managing this issue because even though the response rate was low, there was still an adequate sample. 23, 35, 36, 40, 42 Repeated crosssectional studies featured a widely distinct prevalence estimate on each round. 29, 36, 49, 50 This trend might be caused by the ascending curve of infected people, following the epidemic's natural course. Therefore, there was a need for different sample sizes for each period. Unfortunately, some studies did not yield adequate sample size in all rounds. 49, 50 The same proportion of studies validated their methods internally to report accuracy 16, 21, 23, 24, 30, 32, [34] [35] [36] [37] [38] [39] 45, 50, 52 or used sensitivity and specificity given by manufacturers or other external studies. [18] [19] [20] 22, 36, [40] [41] [42] [44] [45] [46] [47] [48] [49] [50] [51] We also noticed that it is quite unclear if the field teams followed standardized protocols for the data collection and testing. The absence of complete information resulted in a loss of quality in the methodological analysis, 13 and we speculate that one rationale would be the editing process of these articles, which were published as letters or comments. In some studies, 23, 24, 35 the samples were collected by the participants themselves, which causes an increase in the number of discarded samples and can reduce the sensitivity, especially of RT-PCR, highly influenced by a well done sample collection procedure. 57 However, the studies presented several strengths to highlight. Valid methods consistently stated the identification of the condition and the manufacturer indicated this accuracy. The majority of the sampling methods was conducted appropriately regarding randomness, and the participants were well described and stratified, thus FRANCESCHI ET AL. -9 of 15 mitigating possible selection bias. 18, 19, 24, 26, 28, 30, 33, 37, 39, 43, 44, 46, [48] [49] [50] [51] A strong trend was observed in relation to the sampling procedures used in Brazil. All studies used a standardized household sampling method based on census tracts [46] [47] [48] [50] [51] [52] or healthcare units. 49 An interesting method of sample selection was the use of social network ads targeting individuals by demographic and geographic characteristics and stratification, which despite being convenient inserts the biases of technology usage and the participation of people most likely to be infected. However, in these cases, statistical management seems to have been adequate to accommodate the sampling issues in the prevalence estimates. 38, 43 Biases were also introduced when volunteers were recruited, but data analysis was conducted properly in these cases. 41, 43 Nevertheless, these practices cover up important methodological issues despite minimizing the biases of studies and they should be avoided. Covid-19 has an extensive spectrum of manifestation, including asymptomatic infection, mild disease, severe pneumonia and death. 2,9 Asymptomatic individuals may play an important role in viral transmission. 10 The prevalence of asymptomatic infection in the community is still unclear, but essential to estimate the true Covid-19 prevalence. Generally, infection rates are calculated based on tests in symptomatic patients, and it may cause serious underestimations in prevalence. [10] [11] [12] This issue can be circumvented by surveying randomly recruited populations. 11 In fact, the asymptomatic rate of infection is quite hard to estimate. Nevertheless, we can consider some relevant observations. The proportion of symptom-free patients with Covid-19 in most studies is higher than SARS 58 and Middle East respiratory syndrome (MERS) 59 coronavirus epidemics, which was reported to lay between 0% and 7.5%. However, in the case of Covid-19, these rates were widely variable among PCR-positive and/or seropositive, ranging from 19.6% 47 to 69%. 23 The burden of the disease among symptomatic individuals was higher in older age groups, 28, 29 and there was no statistical difference in the viral load of symptomatic versus asymptomatic. 29 On the other hand, RT-PCR-and antibody-negative participants also reported symptoms, 25 It is important to note that the data presented here are based on the articles until 5 September 2020. Therefore, more recent articles are not included in the analysis and a future investigation may identify whether or not these patterns will continue to be observed. In addition, previous preprint articles can be currently published. In general, we believe that the peer review process should contribute to increase the quality of these unpublished articles with a higher risk of bias. We have decided not to conduct a meta-analysis because of the prevalence heterogeneity among studies and the different stages of pandemic faced in the countries and continents at the time of each survey. Thus, a summary measure of meta-analysis would not be able to generalize overall findings sufficiently. In contrast, we found that a correspondence analysis was more able to detect the correlation among variables. In this analysis, few consistent patterns were observed for studies with a high risk of bias, indicating that particular methodo- 13 Therefore, we recommend the use of standardized checklists for the planning, execution and reporting of prevalence studies. Intermediate risk of bias was associated with American and European studies, municipal and regional initiatives, blood samples, P > 1%, and internal/external validation. Low risk of bias was associated with Asian studies, nationwide initiatives, P < 1%, NPS samples and RT-PCR tests. As correspondence analysis is a descriptive statistical analysis, we carefully examined the patterns observed and their frequency to detect only patterns that are effectively consistent. To our knowledge, this is the first systematic review to summarize Covid-19 prevalence surveys in the general population by correlating practices that can influence positively or negatively the methodological quality. Although the number of studies included were relatively low (n = 37) and the correspondence analysis presents some outliers due to the low representativeness of some categories, our findings allowed the identification of practices applied worldwide in Covid-19 prevalence studies associated with the methodological quality. These data may assist researchers in the planning, execution and reporting of future population-based surveys with high methodological quality. Clinical features of patients infected with 2019 novel coronavirus in Wuhan A novel coronavirus from patients with pneumonia in China who-director-general-s-opening-remarks-at-the-media-briefingon-covid WHO coronavirus disease (COVID-19) dashboard COVID-19 MAP. Johns Hopkins Coronavirus Resource Center Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR Coronavirus Disease 2019 (COVID-19) Clinical characteristics of coronavirus disease 2019 in China Defining the epidemiology of Covid-19 -studies needed World Health Organization. Population-based age-stratified seroepidemiological investigation protocol for COVID-19 Virus Infection Laboratory diagnosis of COVID-19: current issues and challenges Methodological guidance for systematic reviews of observational epidemiological studies reporting prevalence and cumulative incidence data Diagnostic accuracy of serological tests for Covid-19: systematic review and meta-analysis Risk-of-bias VISualization (robvis): an R package and Shiny web app for visualizing risk-of-bias assessments Seroprevalence of COVID-19 in Niger state Citywide nucleic acid screening of SARS-CoV-2 infections in post-lockdown Wuhan, China: results and implications Seroprevalence of SARS-CoV-2 in slums and non-slums of Mumbai Seroprevalence of COVID-19 virus infection in Guilan province Seroprevalence of SARS-CoV-2 IgG antibodies in Utsunomiya city, Greater Tokyo, after first pandemic in 2020 (U-CORONA): a household-and population-based study Seroprevalence of SARS-CoV-2 in Palestine: a cross-sectional seroepidemiological study Seroprevalence of SARS-CoV-2-specific antibodies Community prevalence of SARS-CoV-2 virus in England during May 2020: REACT study Antibody prevalence for SARS-CoV-2 in England following first peak of the pandemic: REACT2 study in 100,000 adults Seroprevalence of SARS-CoV-2 antibodies in an entirely PCR-sampled and quarantined community after a COVID-19 outbreak -the CoNAN study Novel coronavirus epidemic in the Hungarian population, a cross-sectional nationwide survey to support the exit policy in Hungary Spread of SARS-CoV-2 in the Icelandic population Seroprevalence of SARS-CoV-2 significantly varies with age: results from a mass population screening Suppression of a SARS-CoV-2 outbreak in the Italian municipality of Vo Prevalence of SARS-CoV-2 infection in the Luxembourgish population: the CON-VINCE study Low prevalence of active COVID-19 in Slovenia: a nationwide population study of a probability-based sample Prevalence of SARS-CoV-2 in Spain (ENE-COVID): a nationwide, population-based seroepidemiological study Seroprevalence against COVID-19 and follow-up of suspected cases in primary health care in Spain Pronounced difference in Covid-19 antibody prevalence indicates cluster transmission in A translational multiplex serology approach to profile the prevalence of anti-SARS-CoV-2 antibodies in home-sampled blood Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Geneva, Switzerland (SEROCoV-POP): a population-based study Seroprevalence of SARS-CoV-2-specific antibodies among adults in Los angeles county COVID-19 antibody sero Seroprevalence of SARS-CoV-2-Specific IgG Antibodies Among Adults Living in Connecticut: post-Infection Prevalence (PIP) Study Estimated community seroprevalence of SARS-CoV-2 antibodies -two Georgia Counties High community SARS-CoV-2 antibody seroprevalence in a Ski resort community Population point prevalence of SARS-CoV-2 infection based on a statewide random sample -Indiana Racial and Workplace Disparities in Seroprevalence of SARS-CoV-2 Seroprevalence of SARS-CoV-2 and Infection Fatality Ratio, Orleans and Jefferson Parishes Community-level SARS-CoV-2 seroprevalence survey in urban slum dwellers of Buenos aires city, Argentina: a participatory research Remarkable variability in SARS-CoV-2 antibodies across Brazilian regions: nationwide serological household survey in 27 states A population-based study of the prevalence of COVID-19 infection in Espirito Santo Brazil: methodology and results of the first stage Population-based seroprevalence of SARS-CoV-2 is more than halfway through the herd immunity threshold in the State of Maranhao, Brazil Sequential serological surveys in the early stages of the coronavirus disease epidemic: limitations and perspectives Population-based surveys of antibodies against SARS-CoV-2 in Southern Brazil SARS-CoV-2 seroprevalence in the municipality of Sao Paulo, Brazil, ten weeks after the first reported case COVID-19 seroprevalence in Baixada Santista metropolitan area Best practices for survey research reports: a synopsis for authors and reviewers Effect of recruitment methods on response rate in a web-based study for primary care physicians: factorial randomized controlled trial A Meta-Analysis of Response Rates in Web-or Internet-Based Surveys Practical issues in calculating the sample size for prevalence studies Real-time RT-PCR in COVID-19 detection: issues affecting the results Seroprevalence of IgG antibodies to SARS-coronavirus in asymptomatic or subclinical population groups Seroprevalence of MERS-CoV in healthy adults in western Saudi Arabia COVID-19: unique public health issues facing Black, Asian and minority ethnic communities Assessing differential impacts of COVID-19 on black communities Ethnic and regional variations in hospital mortality from COVID-19 in Brazil: a cross-sectional observational study Covid-19 epidemic curve in Brazil: a sum of multiple epidemics, whose income inequality and population density in the states are correlated with growth rate and daily acceleration Population-based prevalence surveys during the Covid-19 pandemic: A systematic review The authors would like to thank the included studies for the data provided and for important contributions in facing the pandemic in their countries. This work was supported by grants from Coordenação de Aper- The authors affirm that the processed data supporting our findings are available within the article and its supplementary materials. Raw data are accessible upon request to the corresponding author (Claudia Elizabeth Thompson).